
Accelerated approvals, surrogate end points, and high drug costs are reshaping cancer center formulary decisions, explained panelists at PCOC.
Supplements and Featured Publications
Highlights from the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, which took place on September 11-13, 2019 in Stockholm, Sweden are available in this newsletter published by The American Journal of Managed Care®.






